At halftime, with players locked in a surprising tie with the top-ranked men’s basketball team in the country, the Twitter feed of the University of Maryland-Baltimore County’s athletic department seized the spotlight to make a sales pitch.
I was enjoying a late dinner with friends at Peter Luger Steak House in Brooklyn, N.Y. — the sizzling plates of porterhouse in full command of my attention — when the familiar name began bubbling out of lips at surrounding tables.
The University of Maryland, Baltimore County woke up on Friday as just another small basketball program looking forward to a run against a No. 1 seed in the NCAA tournament.
The FDA’s drive to accelerate access to new medical device technologies continues, with a new product from 3i Diagnostics receiving a Breakthrough Device Designation.
Emerging Technology Centers announced the seven companies that have been accepted into its 2018 Accelerate Baltimore cohort.
Platforms such as Amazon Publishing, Etsy and Instagram have yielded an entire new market of online artists and creators.
Village Capital, a venture capital firm, and Kaiser Permanente have teamed up to address the needs of the aging population in America through a new program called Health: US 2018.
As we celebrate more women becoming medtech leaders and paving the way for innovation, it’s important to remember the many accomplishments women have already made when it comes to the advancement of health and medicine.
Roche is buying out the rest of Flatiron Health for $1.9 billion, the companies said Thursday. The total investment for Roche, a drug maker based in Switzerland, is about $2.1 billion in cash since it already owned about 13% of Flatiron, a tech company that handles electronic health records and data mining specifically for cancer doctors, researchers and patients.
Novavax CEO Stanley Erck said he believes the last quarter was “the most significant in Novavax corporate history.”
The reason? Vaccines, specifically clinical results from the Gaithersburg company’s two lead vaccine programs: RSV for infants via maternal immunization and NanoFlu for seasonal flu.